Items where Author is "Hamad, I."
Group by: Item Type | No Grouping
Number of items: 6.
Hamad, I., Al-Hanbali, O., Hunter, A.C., Rutt, K.J., Andresen, T.L. and Moghimi, S.M. (2010) Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere−serum interface: implications for stealth nanoparticle engineering ACS Nano, 4 (11). pp. 6629-6638. ISSN 1936-0851
Moghimi, S.M., Anderson, A.J., Hashemi, S.H., Lettiero, B., Ahmadvand, D., Hunter, A.C., Andresen, T.L, Hamad, I. and Szebeni, J. (2010) Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead Journal of Controlled Release, 146 (2). pp. 175-181. ISSN 0168-3659
Hamad, I., Hunter, A.C., Rutt, K.J., Liu, Z., Dai, H. and Moghimi, S.M. (2008) Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover Molecular Immunology, 45 (14). pp. 3797-3803. ISSN 0161-5890
Hamad, I., Hunter, A.C., Szebeni, J. and Moghimi, S.M. (2008) Poly(ethylene glycol)s trigger complement activation in human serum through alternative and lectin pathways: a plausible cause for anaphylaxis Molecular Immunology, 46 (2). pp. 225-232. ISSN 0161-5890
Moghimi, S.M., Hamad, I., Bunger, R., Andresen, T.L., Jorgensen, K., Hunter, A.C., Rosivall, L., Baranji, L. and Szebeni, J. (2006) Activation of the Human Complement System by cholesterol-rich and PEGylated liposomes- Modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels Journal of Liposome Research, 16. pp. 167-174. ISSN 0898-2104
Hamad, I. (2008) The molecular basis of complement activation by model nanomedicines. Doctoral thesis, University of Brighton.